PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) reports that it will redeem all outstanding 2 percent Convertible Senior Notes due February ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE